Imagion Biosystems Limited (Company) is committed to ensuring that public confidence is maintained in the Company, its people and the trading of its securities. This policy sets out the company’s trading policy on buying and selling securities of the Company including shares, options, derivatives, managed investment products, superannuation products and any other financial products of the Company that are able to be traded on a financial market (Company’s Securities).
View the Imagion Biosystems Limited Securities Trading Policy.
Positive Final Results of Wayne State Collaboration Drives Completion of Phase 2 Study Protocol for IND Submission to FDA in December
Positive Final Results of Wayne State Collaboration Drives Completion of Phase 2 Study Protocol for IND Submission to FDA in December Key Highlights: MagSense® HER2
